Titlebook: Biomarkers for Alzheimer’s Disease Drug Development; Robert Perneczky Book 2024Latest edition The Editor(s) (if applicable) and The Author

只看該作者 · 發(fā)表于 2025-3-25 03:53:43

Neuroimaging Methods for MRI Analysis in CSF Biomarkers Studieserges as a synergistic approach to understand the structural correlates related with specific AD-related biomarkers. In this chapter, we describe the methods used in neuroimaging that will allow researchers to combine data on CSF metabolites with imaging analyses.

只看該作者 · 發(fā)表于 2025-3-25 08:52:18

只看該作者 · 發(fā)表于 2025-3-25 12:50:59

只看該作者 · 發(fā)表于 2025-3-25 16:05:28

Optimized Pre-analytical Handling Protocol for Blood-Based Biomarkers of Alzheimer’s Diseasemarkers is well established, especially for AD CSF-based biomarkers. In this chapter, we provide recommendations for an optimal sample handling protocol for the analysis of blood-based biomarkers specifically for amyloid pathology in AD.

只看該作者 · 發(fā)表于 2025-3-25 20:51:50

1064-3745 expertsThis fully updated volume provides an up-to-date and comprehensive overview of the current state of technologies helping to accelerate Alzheimer’s disease drug development. Addressing the latest advances in preclinical and clinical research, including new insights into the molecular mechanis

只看該作者 · 發(fā)表于 2025-3-26 00:24:44

只看該作者 · 發(fā)表于 2025-3-26 05:00:39

只看該作者 · 發(fā)表于 2025-3-26 10:17:21

只看該作者 · 發(fā)表于 2025-3-26 14:17:41

Methods in Molecular Biologyhttp://image.papertrans.cn/b/image/187796.jpg

只看該作者 · 發(fā)表于 2025-3-26 17:52:35

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 09:10
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved